Structure

Physi-Chem Properties

Molecular Weight:  616.32
Volume:  637.761
LogP:  4.585
LogD:  2.352
LogS:  -4.212
# Rotatable Bonds:  17
TPSA:  137.82
# H-Bond Aceptor:  10
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.036
Synthetic Accessibility Score:  6.133
Fsp3:  0.618
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.996
MDCK Permeability:  4.167631050222553e-05
Pgp-inhibitor:  0.908
Pgp-substrate:  0.193
Human Intestinal Absorption (HIA):  0.114
20% Bioavailability (F20%):  0.988
30% Bioavailability (F30%):  0.965

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.075
Plasma Protein Binding (PPB):  95.74822235107422%
Volume Distribution (VD):  2.401
Pgp-substrate:  3.4814887046813965%

ADMET: Metabolism

CYP1A2-inhibitor:  0.039
CYP1A2-substrate:  0.045
CYP2C19-inhibitor:  0.102
CYP2C19-substrate:  0.191
CYP2C9-inhibitor:  0.646
CYP2C9-substrate:  0.517
CYP2D6-inhibitor:  0.008
CYP2D6-substrate:  0.096
CYP3A4-inhibitor:  0.744
CYP3A4-substrate:  0.278

ADMET: Excretion

Clearance (CL):  2.265
Half-life (T1/2):  0.095

ADMET: Toxicity

hERG Blockers:  0.224
Human Hepatotoxicity (H-HT):  0.948
Drug-inuced Liver Injury (DILI):  0.958
AMES Toxicity:  0.949
Rat Oral Acute Toxicity:  0.959
Maximum Recommended Daily Dose:  0.985
Skin Sensitization:  0.944
Carcinogencity:  0.196
Eye Corrosion:  0.014
Eye Irritation:  0.02
Respiratory Toxicity:  0.924

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC224660

Natural Product ID:  NPC224660
Common Name*:   Argutin F
IUPAC Name:   [(1S,3R,5R,6aS,7R,8R,10R,10aS)-1,3-diacetyloxy-7-[(2R)-2-hydroperoxy-3-methylidenepent-4-enyl]-10-hydroxy-7,8-dimethyl-1,3,5,6,6a,8,9,10-octahydrobenzo[d][2]benzofuran-5-yl] (2Z,4E)-deca-2,4-dienoate
Synonyms:   Argutin F
Standard InCHIKey:  HXZWRWDSAJYAQI-ASVRBJFWSA-N
Standard InCHI:  InChI=1S/C34H48O10/c1-8-10-11-12-13-14-15-16-30(38)42-25-18-26-31(40-23(5)35)43-32(41-24(6)36)34(26)28(19-25)33(7,22(4)17-29(34)37)20-27(44-39)21(3)9-2/h9,13-16,18,22,25,27-29,31-32,37,39H,2-3,8,10-12,17,19-20H2,1,4-7H3/b14-13+,16-15-/t22-,25+,27-,28+,29-,31+,32-,33-,34-/m1/s1
SMILES:  CCCCC/C=C/C=CC(=O)O[C@H]1C=C2[C@@H](OC(=O)C)O[C@H]([C@]32[C@@H](C1)[C@](C)(C[C@H](C(=C)C=C)OO)[C@H](C)C[C@H]3O)OC(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1651117
PubChem CID:   53322212
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0001757] Colensane and clerodane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22840 Casearia arguta Species Salicaceae Eukaryota n.a. leaf n.a. PMID[21067210]
NPO22840 Casearia arguta Species Salicaceae Eukaryota n.a. n.a. n.a. PMID[21067210]
NPO22840 Casearia arguta Species Salicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT369 Cell Line ACHN Homo sapiens EC50 = 7100.0 nM PMID[484526]
NPT369 Cell Line ACHN Homo sapiens EC50 = 10400.0 nM PMID[484526]
NPT369 Cell Line ACHN Homo sapiens Ratio EC50 = 1.5 n.a. PMID[484526]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC224660 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9899 High Similarity NPC109376
0.98 High Similarity NPC470024
0.9798 High Similarity NPC172867
0.9706 High Similarity NPC470026
0.9608 High Similarity NPC316708
0.9519 High Similarity NPC470027
0.9515 High Similarity NPC17791
0.9423 High Similarity NPC470025
0.9423 High Similarity NPC321272
0.9423 High Similarity NPC317460
0.9423 High Similarity NPC328074
0.9406 High Similarity NPC218158
0.9307 High Similarity NPC470321
0.9307 High Similarity NPC201880
0.9307 High Similarity NPC473207
0.9307 High Similarity NPC264867
0.9307 High Similarity NPC81567
0.9208 High Similarity NPC127933
0.9208 High Similarity NPC7644
0.9208 High Similarity NPC134270
0.9208 High Similarity NPC7613
0.9208 High Similarity NPC475889
0.9126 High Similarity NPC184512
0.9109 High Similarity NPC471363
0.9109 High Similarity NPC238397
0.9038 High Similarity NPC311223
0.9029 High Similarity NPC252296
0.899 High Similarity NPC171598
0.8952 High Similarity NPC316974
0.8952 High Similarity NPC40728
0.8942 High Similarity NPC125423
0.8942 High Similarity NPC88013
0.8911 High Similarity NPC472187
0.8911 High Similarity NPC473204
0.8911 High Similarity NPC473545
0.89 High Similarity NPC98112
0.8889 High Similarity NPC471362
0.8889 High Similarity NPC471372
0.8889 High Similarity NPC472189
0.8868 High Similarity NPC119550
0.8857 High Similarity NPC48548
0.8857 High Similarity NPC135015
0.8857 High Similarity NPC217921
0.8857 High Similarity NPC128795
0.8812 High Similarity NPC471366
0.8812 High Similarity NPC476800
0.8812 High Similarity NPC318917
0.8812 High Similarity NPC472186
0.8713 High Similarity NPC472188
0.8654 High Similarity NPC120009
0.8627 High Similarity NPC474440
0.8585 High Similarity NPC475074
0.8544 High Similarity NPC477968
0.8544 High Similarity NPC477971
0.8544 High Similarity NPC477972
0.8544 High Similarity NPC219285
0.8544 High Similarity NPC161527
0.8544 High Similarity NPC228251
0.8544 High Similarity NPC20113
0.8491 Intermediate Similarity NPC82251
0.8476 Intermediate Similarity NPC45897
0.8447 Intermediate Similarity NPC473154
0.8426 Intermediate Similarity NPC206618
0.8416 Intermediate Similarity NPC88507
0.8407 Intermediate Similarity NPC470914
0.8384 Intermediate Similarity NPC470819
0.8365 Intermediate Similarity NPC324841
0.8349 Intermediate Similarity NPC177047
0.8348 Intermediate Similarity NPC471082
0.8333 Intermediate Similarity NPC38948
0.8319 Intermediate Similarity NPC473828
0.8319 Intermediate Similarity NPC473617
0.8318 Intermediate Similarity NPC239961
0.83 Intermediate Similarity NPC469403
0.83 Intermediate Similarity NPC470817
0.8288 Intermediate Similarity NPC264153
0.8288 Intermediate Similarity NPC473159
0.8288 Intermediate Similarity NPC157441
0.8286 Intermediate Similarity NPC280991
0.8286 Intermediate Similarity NPC198992
0.8252 Intermediate Similarity NPC94905
0.8252 Intermediate Similarity NPC8954
0.8252 Intermediate Similarity NPC165632
0.8252 Intermediate Similarity NPC311166
0.8241 Intermediate Similarity NPC472390
0.8235 Intermediate Similarity NPC470255
0.8224 Intermediate Similarity NPC470768
0.8208 Intermediate Similarity NPC11956
0.8198 Intermediate Similarity NPC194951
0.8198 Intermediate Similarity NPC12046
0.8198 Intermediate Similarity NPC473125
0.8174 Intermediate Similarity NPC257610
0.8155 Intermediate Similarity NPC100892
0.8155 Intermediate Similarity NPC477970
0.8155 Intermediate Similarity NPC477969
0.8155 Intermediate Similarity NPC13924
0.8155 Intermediate Similarity NPC135224
0.8155 Intermediate Similarity NPC276110
0.8148 Intermediate Similarity NPC470767
0.8148 Intermediate Similarity NPC470763
0.8142 Intermediate Similarity NPC207637
0.8137 Intermediate Similarity NPC472812
0.8137 Intermediate Similarity NPC205034
0.8137 Intermediate Similarity NPC152778
0.8137 Intermediate Similarity NPC162615
0.8131 Intermediate Similarity NPC471887
0.8131 Intermediate Similarity NPC132395
0.8131 Intermediate Similarity NPC471886
0.8131 Intermediate Similarity NPC471888
0.8131 Intermediate Similarity NPC471365
0.8131 Intermediate Similarity NPC471885
0.8131 Intermediate Similarity NPC23584
0.8131 Intermediate Similarity NPC471364
0.8131 Intermediate Similarity NPC471450
0.8131 Intermediate Similarity NPC281378
0.8125 Intermediate Similarity NPC290608
0.8125 Intermediate Similarity NPC40133
0.8125 Intermediate Similarity NPC49413
0.8125 Intermediate Similarity NPC44298
0.8125 Intermediate Similarity NPC473128
0.8113 Intermediate Similarity NPC477717
0.8113 Intermediate Similarity NPC472554
0.8103 Intermediate Similarity NPC476204
0.8103 Intermediate Similarity NPC170084
0.81 Intermediate Similarity NPC263079
0.8099 Intermediate Similarity NPC230331
0.8095 Intermediate Similarity NPC278673
0.8077 Intermediate Similarity NPC16967
0.807 Intermediate Similarity NPC203862
0.807 Intermediate Similarity NPC23046
0.8058 Intermediate Similarity NPC104925
0.8058 Intermediate Similarity NPC189513
0.8058 Intermediate Similarity NPC105490
0.8058 Intermediate Similarity NPC469491
0.8058 Intermediate Similarity NPC298973
0.8053 Intermediate Similarity NPC475163
0.8039 Intermediate Similarity NPC472811
0.8037 Intermediate Similarity NPC201191
0.8037 Intermediate Similarity NPC475344
0.8037 Intermediate Similarity NPC471889
0.8037 Intermediate Similarity NPC31058
0.8037 Intermediate Similarity NPC37207
0.8037 Intermediate Similarity NPC469606
0.8037 Intermediate Similarity NPC121423
0.8037 Intermediate Similarity NPC475038
0.8037 Intermediate Similarity NPC472815
0.8037 Intermediate Similarity NPC109195
0.8037 Intermediate Similarity NPC476471
0.8037 Intermediate Similarity NPC472552
0.8037 Intermediate Similarity NPC470571
0.8037 Intermediate Similarity NPC273005
0.8037 Intermediate Similarity NPC150463
0.8036 Intermediate Similarity NPC231797
0.802 Intermediate Similarity NPC470734
0.802 Intermediate Similarity NPC261320
0.8019 Intermediate Similarity NPC477721
0.8019 Intermediate Similarity NPC477716
0.8017 Intermediate Similarity NPC48692
0.8017 Intermediate Similarity NPC135369
0.8 Intermediate Similarity NPC239547
0.8 Intermediate Similarity NPC309503
0.8 Intermediate Similarity NPC155319
0.8 Intermediate Similarity NPC470515
0.8 Intermediate Similarity NPC475263
0.8 Intermediate Similarity NPC125551
0.8 Intermediate Similarity NPC91197
0.8 Intermediate Similarity NPC96597
0.7983 Intermediate Similarity NPC179261
0.7982 Intermediate Similarity NPC51719
0.7982 Intermediate Similarity NPC469607
0.7981 Intermediate Similarity NPC230347
0.7981 Intermediate Similarity NPC275310
0.7981 Intermediate Similarity NPC286612
0.7966 Intermediate Similarity NPC41129
0.7965 Intermediate Similarity NPC287075
0.7963 Intermediate Similarity NPC474575
0.7963 Intermediate Similarity NPC474124
0.7963 Intermediate Similarity NPC85742
0.7961 Intermediate Similarity NPC7349
0.7949 Intermediate Similarity NPC233500
0.7946 Intermediate Similarity NPC65034
0.7946 Intermediate Similarity NPC208189
0.7944 Intermediate Similarity NPC11974
0.7941 Intermediate Similarity NPC471371
0.7941 Intermediate Similarity NPC78973
0.7941 Intermediate Similarity NPC310479
0.7941 Intermediate Similarity NPC471370
0.7941 Intermediate Similarity NPC220216
0.7931 Intermediate Similarity NPC470911
0.7931 Intermediate Similarity NPC304260
0.7931 Intermediate Similarity NPC153085
0.7931 Intermediate Similarity NPC268326
0.7931 Intermediate Similarity NPC5883
0.7931 Intermediate Similarity NPC470517
0.7931 Intermediate Similarity NPC29639
0.7931 Intermediate Similarity NPC219656
0.7931 Intermediate Similarity NPC44899
0.7931 Intermediate Similarity NPC470915
0.7928 Intermediate Similarity NPC475586
0.7928 Intermediate Similarity NPC112457

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC224660 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8103 Intermediate Similarity NPD7503 Approved
0.7838 Intermediate Similarity NPD6686 Approved
0.7797 Intermediate Similarity NPD8033 Approved
0.7712 Intermediate Similarity NPD8294 Approved
0.7712 Intermediate Similarity NPD8377 Approved
0.7692 Intermediate Similarity NPD7327 Approved
0.7692 Intermediate Similarity NPD7328 Approved
0.7647 Intermediate Similarity NPD8296 Approved
0.7647 Intermediate Similarity NPD8380 Approved
0.7647 Intermediate Similarity NPD8335 Approved
0.7647 Intermediate Similarity NPD8378 Approved
0.7647 Intermediate Similarity NPD8379 Approved
0.7627 Intermediate Similarity NPD7516 Approved
0.7593 Intermediate Similarity NPD7638 Approved
0.7523 Intermediate Similarity NPD7640 Approved
0.7523 Intermediate Similarity NPD7639 Approved
0.7431 Intermediate Similarity NPD8029 Clinical (unspecified phase)
0.7431 Intermediate Similarity NPD4225 Approved
0.7429 Intermediate Similarity NPD7838 Discovery
0.7364 Intermediate Similarity NPD6648 Approved
0.7355 Intermediate Similarity NPD8513 Phase 3
0.7355 Intermediate Similarity NPD8516 Approved
0.7355 Intermediate Similarity NPD8515 Approved
0.7355 Intermediate Similarity NPD8517 Approved
0.7353 Intermediate Similarity NPD6400 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD5344 Discontinued
0.7258 Intermediate Similarity NPD7507 Approved
0.7143 Intermediate Similarity NPD7736 Approved
0.7119 Intermediate Similarity NPD6882 Approved
0.7087 Intermediate Similarity NPD7319 Approved
0.7016 Intermediate Similarity NPD6370 Approved
0.7009 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.6983 Remote Similarity NPD6412 Phase 2
0.696 Remote Similarity NPD8328 Phase 3
0.693 Remote Similarity NPD7632 Discontinued
0.6929 Remote Similarity NPD8293 Discontinued
0.6917 Remote Similarity NPD8133 Approved
0.6905 Remote Similarity NPD7492 Approved
0.6885 Remote Similarity NPD7115 Discovery
0.6881 Remote Similarity NPD7637 Suspended
0.6864 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6855 Remote Similarity NPD6054 Approved
0.685 Remote Similarity NPD6616 Approved
0.6833 Remote Similarity NPD8297 Approved
0.6818 Remote Similarity NPD5778 Approved
0.6818 Remote Similarity NPD5779 Approved
0.6807 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6797 Remote Similarity NPD7078 Approved
0.6797 Remote Similarity NPD8074 Phase 3
0.6792 Remote Similarity NPD1694 Approved
0.678 Remote Similarity NPD6899 Approved
0.678 Remote Similarity NPD6881 Approved
0.6757 Remote Similarity NPD7748 Approved
0.675 Remote Similarity NPD6650 Approved
0.675 Remote Similarity NPD6649 Approved
0.675 Remote Similarity NPD8130 Phase 1
0.6748 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6748 Remote Similarity NPD6009 Approved
0.6726 Remote Similarity NPD7902 Approved
0.6698 Remote Similarity NPD7338 Clinical (unspecified phase)
0.6695 Remote Similarity NPD5697 Approved
0.6667 Remote Similarity NPD6015 Approved
0.6667 Remote Similarity NPD6883 Approved
0.6667 Remote Similarity NPD7290 Approved
0.6667 Remote Similarity NPD7102 Approved
0.6667 Remote Similarity NPD6016 Approved
0.6636 Remote Similarity NPD6698 Approved
0.6636 Remote Similarity NPD46 Approved
0.6634 Remote Similarity NPD8264 Approved
0.6614 Remote Similarity NPD5988 Approved
0.6612 Remote Similarity NPD6847 Approved
0.6612 Remote Similarity NPD6617 Approved
0.6612 Remote Similarity NPD8413 Clinical (unspecified phase)
0.6612 Remote Similarity NPD6869 Approved
0.661 Remote Similarity NPD6675 Approved
0.661 Remote Similarity NPD5739 Approved
0.661 Remote Similarity NPD6402 Approved
0.661 Remote Similarity NPD7128 Approved
0.6604 Remote Similarity NPD6695 Phase 3
0.6587 Remote Similarity NPD6319 Approved
0.6587 Remote Similarity NPD6059 Approved
0.6583 Remote Similarity NPD6372 Approved
0.6583 Remote Similarity NPD6013 Approved
0.6583 Remote Similarity NPD6373 Approved
0.6583 Remote Similarity NPD6012 Approved
0.6583 Remote Similarity NPD6014 Approved
0.6577 Remote Similarity NPD6411 Approved
0.6577 Remote Similarity NPD7515 Phase 2
0.6562 Remote Similarity NPD6067 Discontinued
0.6557 Remote Similarity NPD6053 Discontinued
0.6555 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6518 Remote Similarity NPD6399 Phase 3
0.6514 Remote Similarity NPD7750 Discontinued
0.6509 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6504 Remote Similarity NPD4632 Approved
0.65 Remote Similarity NPD6011 Approved
0.65 Remote Similarity NPD7320 Approved
0.6471 Remote Similarity NPD6008 Approved
0.6466 Remote Similarity NPD7260 Phase 2
0.646 Remote Similarity NPD7901 Clinical (unspecified phase)
0.646 Remote Similarity NPD7900 Approved
0.6434 Remote Similarity NPD7829 Approved
0.6434 Remote Similarity NPD7830 Approved
0.6429 Remote Similarity NPD7983 Approved
0.6429 Remote Similarity NPD6079 Approved
0.6417 Remote Similarity NPD5701 Approved
0.6417 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6404 Remote Similarity NPD1698 Clinical (unspecified phase)
0.6396 Remote Similarity NPD6101 Approved
0.6396 Remote Similarity NPD6051 Approved
0.6396 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6381 Remote Similarity NPD7645 Phase 2
0.6381 Remote Similarity NPD6929 Approved
0.6364 Remote Similarity NPD7524 Approved
0.6356 Remote Similarity NPD5211 Phase 2
0.6348 Remote Similarity NPD7839 Suspended
0.6325 Remote Similarity NPD4696 Approved
0.6325 Remote Similarity NPD5286 Approved
0.6325 Remote Similarity NPD5285 Approved
0.6321 Remote Similarity NPD7525 Registered
0.6321 Remote Similarity NPD6930 Phase 2
0.6321 Remote Similarity NPD7514 Phase 3
0.6321 Remote Similarity NPD7332 Phase 2
0.6321 Remote Similarity NPD6931 Approved
0.6308 Remote Similarity NPD7604 Phase 2
0.6293 Remote Similarity NPD6083 Phase 2
0.6293 Remote Similarity NPD6084 Phase 2
0.6286 Remote Similarity NPD7145 Approved
0.6279 Remote Similarity NPD5983 Phase 2
0.6273 Remote Similarity NPD3618 Phase 1
0.6262 Remote Similarity NPD6902 Approved
0.626 Remote Similarity NPD6371 Approved
0.625 Remote Similarity NPD7100 Approved
0.625 Remote Similarity NPD5141 Approved
0.625 Remote Similarity NPD7101 Approved
0.625 Remote Similarity NPD5328 Approved
0.6232 Remote Similarity NPD7966 Clinical (unspecified phase)
0.623 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6218 Remote Similarity NPD5225 Approved
0.6218 Remote Similarity NPD5226 Approved
0.6218 Remote Similarity NPD5224 Approved
0.6218 Remote Similarity NPD4633 Approved
0.6216 Remote Similarity NPD4251 Approved
0.6216 Remote Similarity NPD4250 Approved
0.6212 Remote Similarity NPD6336 Discontinued
0.621 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6207 Remote Similarity NPD5221 Approved
0.6207 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6207 Remote Similarity NPD5222 Approved
0.6203 Remote Similarity NPD7799 Discontinued
0.6195 Remote Similarity NPD5785 Approved
0.619 Remote Similarity NPD6925 Approved
0.619 Remote Similarity NPD6932 Approved
0.619 Remote Similarity NPD5776 Phase 2
0.6181 Remote Similarity NPD7625 Phase 1
0.6176 Remote Similarity NPD6845 Suspended
0.6172 Remote Similarity NPD6335 Approved
0.6168 Remote Similarity NPD8259 Clinical (unspecified phase)
0.6167 Remote Similarity NPD5175 Approved
0.6167 Remote Similarity NPD5174 Approved
0.6154 Remote Similarity NPD4755 Approved
0.6154 Remote Similarity NPD5173 Approved
0.6154 Remote Similarity NPD8039 Approved
0.6154 Remote Similarity NPD6942 Approved
0.6154 Remote Similarity NPD7339 Approved
0.6142 Remote Similarity NPD6868 Approved
0.6142 Remote Similarity NPD6274 Approved
0.614 Remote Similarity NPD5284 Approved
0.614 Remote Similarity NPD5281 Approved
0.614 Remote Similarity NPD8034 Phase 2
0.614 Remote Similarity NPD7087 Discontinued
0.614 Remote Similarity NPD8035 Phase 2
0.6134 Remote Similarity NPD5223 Approved
0.6129 Remote Similarity NPD4634 Approved
0.6126 Remote Similarity NPD6684 Approved
0.6126 Remote Similarity NPD7521 Approved
0.6126 Remote Similarity NPD5330 Approved
0.6126 Remote Similarity NPD7146 Approved
0.6126 Remote Similarity NPD7334 Approved
0.6126 Remote Similarity NPD6409 Approved
0.6126 Remote Similarity NPD4249 Approved
0.6121 Remote Similarity NPD5695 Phase 3
0.6119 Remote Similarity NPD6033 Approved
0.6098 Remote Similarity NPD4729 Approved
0.6098 Remote Similarity NPD4730 Approved
0.6095 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6094 Remote Similarity NPD6317 Approved
0.6091 Remote Similarity NPD4786 Approved
0.609 Remote Similarity NPD8451 Approved
0.6087 Remote Similarity NPD4202 Approved
0.6071 Remote Similarity NPD4751 Clinical (unspecified phase)
0.6071 Remote Similarity NPD3573 Approved
0.6058 Remote Similarity NPD6926 Approved
0.6058 Remote Similarity NPD6924 Approved
0.6055 Remote Similarity NPD3667 Approved
0.6055 Remote Similarity NPD5209 Approved
0.605 Remote Similarity NPD4700 Approved
0.6047 Remote Similarity NPD7641 Discontinued
0.6047 Remote Similarity NPD6314 Approved
0.6047 Remote Similarity NPD6313 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data